An Update on Preventive Outlook for Supplementation of Vitamin-D against SARS-CoV-2 Infection
- Department of Biochemistry and Molecular Biology, Faculty of Life Sciences, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh
- Laboratory Department of Pharmacy, Faculty of Life Sciences, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh
PLOMSE Review Journal 2024, 1(1)
- Submission received
- 7 August 2021
- Accepted
- 4 March 2024
- Published
- 4 March 2024
Mohammad Saikat, A. & Torequl Islam, M., (2024) “An Update on Preventive Outlook for Supplementation of Vitamin-D against SARS-CoV-2 Infection”, PLOMSE Review Journal 1(1).
Abstract
The pandemic COVID-19 has a high death rate, which threatens nearly most of the world's population. The main reason for mortality in severe acute respiratory syndrome is intensified inflammatory activity followed by oxidative stress and inflammatory reactions on the lungs. To date, this pathology does not have a clear and conclusive cure troubling the world population, particularly elderly adults who are the major risk groups. In this sense, assessing the effectiveness of current pharmacological agents, which can be used to resolve or attenuate this pulmonary complication's seriousness that has threatened the lives of so many people globally, is of particular importance. In contrast to quarantine, public health interventions are urgently needed, reducing the risk of illness and death. Evidence reveals that vitamin D supplementation may be possible in treating COVID-19. Additionally, numerous trials and studies started to study the effect of vitamin D supplementation on patients with SARS-CoV-2 infection.
Keywords
© 2024 by the authors. Licensee PLOMSE, Richardson, TX, USA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.